de Jong-van den Berg LT - Search Results

1

The use of birth defect registries for etiological research: a review.

Reefhuis J, de Jong-van den Berg LT, Cornel MC. Reefhuis J, et al. Community Genet. 2002;5(1):13-32. doi: 10.1159/000064628. Community Genet. 2002. PMID: 14960897

2

The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.

Meijer WM, Cornel MC, Dolk H, de Walle HE, Armstrong NC, de Jong-van den Berg LT; EUROCAT Working Group. Meijer WM, et al. Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):675-82. doi: 10.1002/pds.1265. Pharmacoepidemiol Drug Saf. 2006. PMID: 16761260

3

Periconceptional folic acid in The Netherlands in 1995. Socioeconomic differences.

de Walle HE, van der Pal KM, de Jong-van den Berg LT, Schouten J, de Rover CM, Buitendijk SE, Cornel MC. de Walle HE, et al. J Epidemiol Community Health. 1998 Dec;52(12):826-7. doi: 10.1136/jech.52.12.826. J Epidemiol Community Health. 1998. PMID: 10396527 Free PMC article. No abstract available.

4

Additional information from parental questionnaires and pharmacy records for registration of birth defects. EuroMAP-group.

Reefhuis J, de Walle HE, de Jong-van den Berg LT, Cornel MC. Reefhuis J, et al. Eur J Epidemiol. 2000 Apr;16(4):329-36. doi: 10.1023/a:1007656619529. Eur J Epidemiol. 2000. PMID: 10959940

5

Registration of drug use in a birth defect monitoring system: a priority worthy of emphasis!

de Vries CS, de Walle HE, Cornel MC, de Jong-van den Berg LT. de Vries CS, et al. Int J Risk Saf Med. 1993;4(1):27-33. doi: 10.3233/JRS-1993-4104. Int J Risk Saf Med. 1993. PMID: 23511175

6

Three years after the dutch folic acid campaign: growing socioeconomic differences.

de Walle HE, Cornel MC, de Jong-van den Berg LT. de Walle HE, et al. Prev Med. 2002 Jul;35(1):65-9. doi: 10.1006/pmed.2002.1040. Prev Med. 2002. PMID: 12079442

7

Folic acid--the scientific debate as a base for public health policy.

Cornel MC, de Smit DJ, de Jong-van den Berg LT. Cornel MC, et al. Reprod Toxicol. 2005 Sep-Oct;20(3):411-5. doi: 10.1016/j.reprotox.2005.03.015. Reprod Toxicol. 2005. PMID: 15978774 Review.

8

[Indications for an increased risk of neural tube defects in pregnancies following ovulation induction and (or) in-vitro fertilization].

Cornel MC, de Jong-van den Berg LT, Koudstaal J, Wiegerinck MA, te Meerman GJ, ten Kate LP. Cornel MC, et al. Ned Tijdschr Geneeskd. 1990 Jul 14;134(28):1357-61. Ned Tijdschr Geneeskd. 1990. PMID: 2374625 Dutch.

9

Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. Europen Medicine and Pregnancy Group.

De Jong van den Berg LT, Feenstra N, Sorensen HT, Cornel MC. De Jong van den Berg LT, et al. Teratology. 1999 Jul;60(1):33-6. doi: 10.1002/(SICI)1096-9926(199907)60:1<33::AID-TERA9>3.0.CO;2-X. Teratology. 1999. PMID: 10413337

10

[Peri-pregnancy folic acid supplementation must be improved].

de Smid DJ, de Jong-van den Berg LT, Cornel MC. de Smid DJ, et al. Ned Tijdschr Geneeskd. 2012;156(41):A4512. Ned Tijdschr Geneeskd. 2012. PMID: 23062252 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters